Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. | Elife | 2023 | 38127790 | PubTator, text mining | PubMed |
| The lncRNA Malat1 inhibits miR-15/16 to enhance cytotoxic T cell activation and memory cell formation. | Elife | 2023 | 38127070 | PubTator, text mining | PubMed |
| Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. | Nat Commun | 2023 | 38110410 | PubTator, text mining | PubMed |
| Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis. | Nat Commun | 2023 | 38097562 | PubTator, text mining | PubMed |
| Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia. | Front Immunol | 2023 | 38094307 | PubTator, text mining | PubMed |
| Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation. | Pathol Oncol Res | 2023 | 38089646 | PubTator, text mining | PubMed |
| The effect of metformin on senescence of T lymphocytes. | Immun Ageing | 2023 | 38087369 | PubTator, text mining | PubMed |
| Immunological link between periodontitis and type 2 diabetes deciphered by single-cell RNA analysis. | Clin Transl Med | 2023 | 38082425 | PubTator, text mining | PubMed |
| Amniotic MSC affect CD8 naive polarization toward SLEC/MPEC subsets by down-modulating IL-12Rβ1 and IL-2Rα signaling pathways. | iScience | 2023 | 38077154 | PubTator, text mining | PubMed |
| Recent progress of covalent organic frameworks membranes: Design, synthesis, and application in water treatment. | Eco Environ Health | 2023 | 38074995 | PubTator, text mining | PubMed |
| Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma. | Front Oncol | 2023 | 38074649 | PubTator, text mining | PubMed |
| Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC. | Cancers (Basel) | 2023 | 38067293 | PubTator, text mining | PubMed |
| Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis. | Sci Immunol | 2023 | 38064568 | PubTator, text mining | PubMed |
| Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer. | J Transl Med | 2023 | 38062450 | PubTator, text mining | PubMed |
| TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma. | iScience | 2023 | 38053639 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Interleukin-9 production by type 2 innate lymphoid cells induces Paneth cell metaplasia and small intestinal remodeling. | Nat Commun | 2023 | 38042840 | PubTator, text mining | PubMed |
| Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma. | J Immunother Cancer | 2023 | 38040420 | PubTator, text mining | PubMed |
| Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. | Sci Adv | 2023 | 38039364 | PubTator, text mining | PubMed |
| Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment. | Nat Commun | 2023 | 38036590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=13